Viewing Study NCT06620835

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-06-04 @ 7:57 PM
Study NCT ID: NCT06620835
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2024-09-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
Sponsor: Groupe Francais De Pneumo-Cancerologie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NSCLC View
None Lung cancer View
None ALK rearrangement View
None gene mutation View